GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

The organizational chart of GSK displays its 195 main executives including Emma Walmsley, Julie Brown, Luke Miels and Adam Walker

Our board of directors is responsible for corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance. Our Chief Executive Officer is responsible for the management of the business …

We track progress in six priority areas to build trust: access, global health and health security, environment, inclusion, ethical standards, and product governance. Our Corporate Responsibility Committee oversees and monitors GLT’s progress against these six priority areas to build trust.

Prior to her appointment as GSK’s CEO, Emma was the CEO of GSK Consumer Healthcare, a Joint Venture between GSK and Novartis, from its creation in March 2015. Emma joined GSK in 2010 from L’Oreal, having worked for 17 years in a variety of roles in Paris, London, New York and Shanghai. Emma was previously a Non-Executive Director of Diageo plc.

The Leadership Team at GSK is responsible for setting the strategic direction and operational oversight of the company.

The organizational chart of GSK USA displays its 22 main executives including Maya Martinez-Davis and Lisa Martin

El organigrama de GSK muestra a sus 195 principales ejecutivos de los cuales Emma Walmsley, Julie Brown, Luke Miels y Adam Walker

Jan 7, 2025 · The organizational chart of GSK Germany displays its 2 main executives including Victoria Williams

L'organigramme de GSK contient ses 195 principaux dirigeants dont Emma Walmsley, Julie Brown, Luke Miels et Adam Walker